| Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women BT Bateman, JM Franklin, K Bykov, J Avorn, WH Shrank, TA Brennan, ... American journal of obstetrics and gynecology 215 (3), 353. e1-353. e18, 2016 | 269 | 2016 |
| Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation JD Seeger, K Bykov, DB Bartels, K Huybrechts, K Zint, S Schneeweiss Thrombosis and haemostasis 114 (12), 1277-1289, 2015 | 148 | 2015 |
| Patterns and predictors of persistent opioid use following hip or knee arthroplasty SC Kim, N Choudhry, JM Franklin, K Bykov, M Eikermann, J Lii, ... Osteoarthritis and cartilage 25 (9), 1399-1406, 2017 | 147 | 2017 |
| Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case–control studies AS Kesselheim, K Bykov, J Avorn, A Tong, M Doherty, NK Choudhry Annals of internal medicine 161 (2), 96-103, 2014 | 118 | 2014 |
| Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study BT Bateman, K Bykov, NK Choudhry, S Schneeweiss, JJ Gagne, ... Bmj 347, 2013 | 99 | 2013 |
| Eliminating medication copayments reduces disparities in cardiovascular care NK Choudhry, K Bykov, WH Shrank, M Toscano, WS Rawlins, L Reisman, ... Health affairs 33 (5), 863-870, 2014 | 97 | 2014 |
| Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison JJ Gagne, K Bykov, NK Choudhry, TJ Toomey, JG Connolly, J Avorn BmJ 347, 2013 | 76 | 2013 |
| Association of gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States K Bykov, BT Bateman, JM Franklin, SM Vine, E Patorno JAMA network open 3 (12), e2031647-e2031647, 2020 | 55 | 2020 |
| Confounding of the association between statins and Parkinson disease: systematic review and meta‐analysis K Bykov, K Yoshida, MG Weisskopf, JJ Gagne Pharmacoepidemiology and drug safety 26 (3), 294-300, 2017 | 50 | 2017 |
| Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study MM Donneyong, K Bykov, P Bosco-Levy, YH Dong, R Levin, JJ Gagne bmj 354, 2016 | 46 | 2016 |
| Pharmacy-based interventions to reduce primary medication nonadherence to cardiovascular medications MA Fischer, NK Choudhry, K Bykov, G Brill, G Bopp, AM Wurst, ... Medical Care 52 (12), 1050-1054, 2014 | 43 | 2014 |
| Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection C Gopalakrishnan, K Bykov, MA Fischer, JG Connolly, JJ Gagne, ... JAMA internal medicine 180 (12), 1596-1605, 2020 | 42 | 2020 |
| Switching generic antiepileptic drug manufacturer not linked to seizures: a case-crossover study AS Kesselheim, K Bykov, JJ Gagne, SV Wang, NK Choudhry Neurology 87 (17), 1796-1801, 2016 | 34 | 2016 |
| Impact of an interaction between clopidogrel and selective serotonin reuptake inhibitors K Bykov, S Schneeweiss, MM Donneyong, YH Dong, NK Choudhry, ... The American Journal of Cardiology 119 (4), 651-657, 2017 | 33 | 2017 |
| Non‐steroidal anti‐inflammatory drug administration after coronary artery bypass surgery: utilization persists despite the boxed warning A Kulik, K Bykov, NK Choudhry, BT Bateman Pharmacoepidemiology and drug safety 24 (6), 647-653, 2015 | 33 | 2015 |
| Thiazolidinediones and Parkinson disease: a cohort study JG Connolly, K Bykov, JJ Gagne American journal of epidemiology 182 (11), 936-944, 2015 | 32 | 2015 |
| Treatment dynamics of newly marketed drugs and implications for comparative effectiveness research JJ Gagne, K Bykov, RJ Willke, KH Kahler, P Subedi, S Schneeweiss Value in health 16 (6), 1054-1062, 2013 | 32 | 2013 |
| Clinical outcomes of concomitant use of warfarin and selective serotonin reuptake inhibitors: a multidatabase observational cohort study YH Dong, K Bykov, NK Choudhry, MM Donneyong, KF Huybrechts, ... Journal of Clinical Psychopharmacology 37 (2), 200-209, 2017 | 20 | 2017 |
| Glucose‐lowering medications and the risk of cancer: a methodological review of studies based on real‐world data K Bykov, M He, JM Franklin, EM Garry, JD Seeger, E Patorno Diabetes, Obesity and Metabolism 21 (9), 2029-2038, 2019 | 17 | 2019 |
| Generating evidence of clinical outcomes of drug–drug interactions K Bykov, JJ Gagne Drug safety 40, 101-103, 2017 | 17 | 2017 |
Sebastian Schneeweiss, M.D., Sc.D.Professor of Medicine and Epidemiology, Harvard Medical SchoolDirección de correo verificada de post.harvard.edu
